Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
26.87
+1.18 (4.59%)
At close: Aug 13, 2025, 4:00 PM
26.92
+0.05 (0.19%)
After-hours: Aug 13, 2025, 7:57 PM EDT
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $19.96 billion as of August 13, 2025. Its market cap has increased by 171.06% in one year.
Market Cap
19.96B
Enterprise Value
19.67B
1-Year Change
171.06%
Ranking
Category
Stock Price
$26.87
Market Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $19.96B, an increase of 16,673.35%. That is a compound annual growth rate of 63.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 20.99B | 59.47% |
| Dec 31, 2024 | 13.16B | 619.43% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| UnitedHealth Group | 228.56B |
| Novo Nordisk | 222.88B |